Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,662,533
-$716 QoQ
Shares Held
12,938
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,718
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. MRK ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
|
3,608 | $565,445 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,662,533 | 12,938 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,663,249 | 13,827 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,476,587 | 14,028 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,177,453 | 14,029 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,098,661 | 13,879 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,413,271 | 15,745 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,897,978 | 19,079 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,164,680 | 19,062 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,761,482 | 22,306 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,378,002 | 18,022 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,001,171 | 18,356 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,261,090 | 21,963 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,504,424 | 21,704 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,275,256 | 21,386 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,421,705 | 21,827 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,790,090 | 20,786 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,782,738 | 19,554 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,603,092 | 19,538 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,713,747 | 22,361 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,679,534 | 22,361 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,894,632 | 24,362 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,885,776 | 24,462 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,000,990 | 24,462 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,004,072 | 24,160 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,863,885 | 24,103 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,861,177 | 24,190 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||